Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

LMLLF Relative to the S&P 500

Seasonal Chart Analysis

Analysis of the Pharmadrug Inc. (OTCMKT:LMLLF) seasonal charts above shows that a Buy Date of December 18 and a Sell Date of March 10 has resulted in a geometric average return of 27.81% above the benchmark rate of the S&P 500 Total Return Index over the past 8 years. This seasonal timeframe has shown positive results compared to the benchmark in 7 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 8 years by an average of 63.91% per year.

A word of caution: Only 8 years of data is available for shares of LMLLF, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

Pharmadrug, Inc. engages in the research, development, and commercialization of controlled substances and natural medicines such as psychedelics, cannabis and naturally derived approved drugs. It specializes in researching and reformulating established natural medicines with a goal of bringing them through clinical trials and the associated regulatory approval process in the U.S and Europe. The company was founded on September 6, 2011 and is headquartered in Toronto, Canada.

To download LMLLF seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: LMLLF